Drugs / PF-04287881
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01026545 | Dec 2009 → Jul 2010 | respiratory tract infectious disorder | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT00793000 | Nov 2008 → Dec 2009 | respiratory tract infectious disorder | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-04287881 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00793000 ↗ |
| Route | Oral | “75 mg oral dose (prepared solution) given once” NCT00793000 ↗ |